Bennet Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 31-08-2024
- Paid Up Capital ₹ 4.34 Cr
as on 31-08-2024
- Company Age 21 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 53.17 Cr
as on 31-08-2024
- Satisfied Charges ₹ 13.18 Cr
as on 31-08-2024
- Revenue -23.80%
(FY 2023)
- Profit -17.95%
(FY 2023)
- Ebitda -25.80%
(FY 2023)
- Net Worth 14.76%
(FY 2023)
- Total Assets 22.83%
(FY 2023)
About Bennet Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 4.34 Cr.
The company currently has active open charges totaling ₹53.17 Cr. The company has closed loans amounting to ₹13.18 Cr, as per Ministry of Corporate Affairs (MCA) records.
Jambukumar Jain, Siddarth Jain, and Vaishali Jain serve as directors at the Company.
- CIN/LLPIN
U24231GJ2003PLC043204
- Company No.
043204
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
20 Nov 2003
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Bennet Pharmaceuticals Limited offer?
Bennet Pharmaceuticals Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Antacid Drugs, Antihistamines, Anti Cold Tablet, Anti Infective Drugs & Medicines, Malaria Medicine, Anti Infective Agent, Antibiotic Injection, Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs.
Who are the key members and board of directors at Bennet Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Siddarth Jain  | Managing Director | 31-Mar-2018 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jambukumar Jain | Director | 20-Nov-2003 | Current |
| Vaishali Jain | Whole-Time Director | 01-Dec-2020 | Current |
Financial Performance of Bennet Pharmaceuticals.
Bennet Pharmaceuticals Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 23.8% decrease. The company also saw a substantial fall in profitability, with a 17.95% decrease in profit. The company's net worth Soared by an impressive increase of 14.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bennet Pharmaceuticals?
In 2023, Bennet Pharmaceuticals had a promoter holding of 73.46% and a public holding of 26.54%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Jkj Pharmaceuticals Private LimitedActive 1 year 2 months
Jambukumar Jain and Siddarth Jain are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 12 Mar 2024 | ₹3.70 Cr | Open |
Axis Bank Limited Creation Date: 27 Mar 2023 | ₹24.50 Cr | Open |
Others Creation Date: 27 Jan 2023 | ₹4.05 M | Open |
How Many Employees Work at Bennet Pharmaceuticals?
Bennet Pharmaceuticals has a workforce of 356 employees as of Aug 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bennet Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bennet Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
